PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsabsence epilepsy
MeSH D004832 - absence epilepsy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004829:Generalized epilepsy
0 Companies
0 Drugs
Success rate
D000073376:Epileptic syndromes
1 Company
1 Drug
$
Success rate
D004832: 
Absence epilepsy
52 Companies
7 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaEthosuximide Ethosuximide  1993-07-30   
Divalproex sodium Divalproex  2008-07-29   
MylanDivalproex sodium Divalproex  2008-07-29   
AbbVieValproic acid Depakene  1982-01-01   
Divalproex sodium Depakote  1983-03-10   
Valproic acid Depacon  1996-12-30   
PfizerEthosuximide Zarontin  1982-01-01   
Aurobindo PharmaDivalproex sodium Divalproex  2011-04-21   
Sun Pharmaceutical IndustriesValproic acid Valproic Acid  2013-02-22   
Divalproex sodium Divalproex  2008-07-29   
Alembic PharmaceuticalsDivalproex sodium Divalproex  2024-12-19   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/1
Phase 3
73%
8/11
Approved: 6Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Divalproex sodium
Mylan
Clonazepam,
Divalproex sodium
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use